1. Hong Kong Stocks

  2. •

    Healthcare

  3. •

    Medical - Care Facilities
C-MER Medical Holdings Limited

C-MER Medical Holdings Limited

3309.HK
C-MER Medical Holdings LimitedHK flagHong Kong Stock Exchange
0.92
HKD
-0.02
- -
1.09BMarket Cap
C-MER Medical Holdings Limited
3309.HK
(Hong Kong Stock Exchange)

Recent

price

0.92

P/E

ratio

- -

div

yld

- -

ROIC.AI

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
0.16
0.2
0.25
0.31
0.42
0.55
0.63
0.97
1.4
1.53
1.55
1.61
Revenue per Share
0.02
0.04
0.05
0.04
0.04
0.04
-0.01
0.02
-0.02
0.05
-0.11
0.08
Basic EPS, GAAP
0.03
0.05
0.04
- -
0.01
-0.03
-0.1
0.01
0.06
0.2
0.1
0.17
Free Cash Flow per Basic Share
- -
- -
- -
0.07
- -
0.02
0.02
0.02
- -
- -
- -
- -
Dividend per Share
0.03
0.07
0.07
0.02
0.16
0.18
0.15
0.14
0.12
0.16
0.05
0.11
Book Value per Share
0.03
0.07
0.06
0.15
0.81
0.68
0.74
0.69
0.71
0.72
0.75
0.76
Tangible Book Value per Share
1,000
1,000
1,000
1,000
1,022
1,046
1,104
1,148
1,233
1,256
1,233
1,206
Basic Weighted Avg Shares
156
199
249
311
429
576
700
1,113
1,732
1,924
1,913
1,947
Sales/Revenue/Turnover
19.22
25.38
22.75
18.13
13.03
8.37
-0.91
0.19
-0.9
6.22
2.85
6.94
Operating Margin (%)
11
12
12
9
26
79
114
149
224
221
331
199
Depreciation Expense
22
38
47
40
43
41
-6
22
-22
62
-135
100
Net Income, GAAP
20.03
20.8
19.98
31.39
30.4
26.47
435.94
39.61
- -
30.53
- -
28.51
Effective Tax Rate (%)
14.29
19.29
18.86
12.89
9.91
7.19
-0.89
1.96
-1.26
3.22
-7.06
5.16
Profit Margin (%)
-12
32
22
35
711
452
459
338
332
331
230
203
Working Capital
7
6
1
1
2
128
177
206
303
246
299
256
LT Debt
31
67
63
157
834
861
1,297
1,337
1,998
1,993
1,890
1,937
Total Equity
- -
42.39
46.39
29.82
7.69
3.76
1.65
0.08
- -
3.43
- -
4.09
Return on Invested Capital (%)
- -
45.04
51.29
68.68
42.17
18.51
-9.98
6.68
- -
6.93
- -
15.68
Return on Capital (%)
- -
78.85
70.03
88.69
44.58
23.43
-3.53
13.12
-13.73
34.82
-100.97
99.78
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
67.6%
9.91%
2.47%
Free Cash Flow
-65.74%
103.79%
63.73%
Net Income, GAAP
-162.96%
-305.15%
-174.26%
Sales/Revenue/Turnover
27.08%
25.4%
1.75%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1,924
2024
- -
- -
- -
- -
1,913
2025
- -
- -
- -
- -
1,947

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.05
2024
- -
- -
- -
- -
-0.11
2025
- -
- -
- -
- -
0.08

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Similar Companies
Sienna Senior Living Inc. (SIA.TO)
Max Healthcare Institute Ltd (MAXHEALTH.BO)
Yonghe Medical Group Co., Ltd. (2279.HK)
Suraksha Diagnostic Ltd. (SURAKSHA.NS)
Jiangxi Rimag Group Co., Ltd. (2522.HK)
C-MER Medical Holdings Limited (3309.HK)
Business
C-MER Medical Holdings Limited is a Hong Kong-based integrated medical group specializing in comprehensive specialty medical services with a core focus on ophthalmology. The company operates through multiple business segments including ophthalmic services, dental services, oncology, medical aesthetics, and general practice. It offers a broad range of products and services including cataract, glaucoma, strabismus, and refractive surgeries; vision aid products such as glasses and lenses; pharmaceutical and medical consumables; as well as specialized medical examinations and treatments. C-MER Medical manages over 30 medical facilities across Hong Kong and maintains a nationwide network of eye and dental hospitals and clinics in Mainland China, including major cities in the Greater Bay Area such as Shenzhen and Guangzhou, as well as Beijing, Shanghai, Kunming, and Huizhou. Founded in 2012 and headquartered in Central, Hong Kong, the company employs more than 1,400 staff and operates with a commitment to professional, high-quality, one-stop specialty medical care. Recently, C-MER Medical Holdings Limited completed a strategic Series A investment of US$1 million into Health Hope Pharma, a clinical-stage biotech company focusing on oral anti-cancer drug development, which has expanded the company’s portfolio into oncology pharmaceutical innovation. The company also changed its name from C-MER Eye Care Holdings Limited to C-MER Medical Holdings Limited in June 2024 to reflect its broadened healthcare service offerings beyond eye care. Additionally, C-MER Medical has engaged in share repurchase programs to optimize its capital structure. These developments signify the company's strategic expansion in both geographic reach and service breadth, reinforcing its position in the healthcare industry across Hong Kong and Mainland China.